AAAAAA
Results: 1-25/41
Authors:
BELLONI SONZOGNI A
GIANI C
RIPAMONTI C
RIVA F
Citation: A. Belloni Sonzogni et al., EFFETTO DI UN TRATTAMENTO PSICOTERAPICO DI GRUPPO IN PAZIENTI GERIATRICHE DEPRESSE E ANSIOSE, Ricerche di psicologia , XVIII(2), 1994, pp. 135-149
Authors:
GNUDI S
MALAVOLTA N
RIPAMONTI C
CAUDARELLA R
Citation: S. Gnudi et al., Ultrasound transmission velocity at the patella: normative data in the italian female population, Italian journal of mineral & electrolyte metabolism (Print) Italian journal of mineral and electrolyte metabolism , 10(3-4), 1996, pp. 145-148
Authors:
RIPAMONTI C
DECONNO F
BOFFI R
ASCANI L
BIANCHI M
Citation: C. Ripamonti et al., CAN SOMATOSTATIN BE ADMINISTERED IN ASSOCIATION WITH MORPHINE IN ADVANCED CANCER-PATIENTS WITH PAIN, Annals of oncology, 9(8), 1998, pp. 921-923
Authors:
RIPAMONTI C
DECONNO F
GROFF L
BELZILE M
PEREIRA J
HANSON J
BRUERA E
Citation: C. Ripamonti et al., EQUIANALGESIC DOSE RATIO BETWEEN METHADONE AND OTHER OPIOID AGONISTS IN CANCER PAIN - COMPARISON OF 2 CLINICAL-EXPERIENCES/, Annals of oncology, 9(1), 1998, pp. 79-83
Authors:
RIPAMONTI C
FULFARO F
POLASTRI D
DECONNO F
LAFFRANCHI A
MOLITERNI A
Citation: C. Ripamonti et al., PAIN RELIEF AND SCLEROSIS OF BONE METASTASES IN A PATIENT WITH BREAST-CANCER TREATED WITH TAMOXIFEN, RADIOTHERAPY AND PAMIDRONATE DISODIUM - WHICH TREATMENT HELPED, Journal of pain and symptom management, 16(2), 1998, pp. 73-76
Authors:
RIPAMONTI C
GROFF L
BRUNELLI C
POLASTRI D
STAVRAKIS A
DECONNO F
Citation: C. Ripamonti et al., SWITCHING FROM MORPHINE TO ORAL METHADONE IN TREATING CANCER PAIN - WHAT IS THE EQUIANALGESIC DOSE RATIO, Journal of clinical oncology, 16(10), 1998, pp. 3216-3221
Authors:
RIPAMONTI C
FULFARO F
BRUERA E
Citation: C. Ripamonti et al., DYSPNEA IN PATIENTS WITH ADVANCED CANCER - INCIDENCE, CAUSES AND TREATMENTS, Cancer treatment reviews, 24(1), 1998, pp. 69-80
Authors:
BEGHINI A
CASTORINA P
CAIROLI R
RIPAMONTI C
MORRA E
LARIZZA L
Citation: A. Beghini et al., TRISOMY 4 AND C-KIT MUTATION IN A T(8-21) MYELOID-LEUKEMIA WITH MAST-CELL INVOLVEMENT, Cytogenetics and cell genetics, 81(2), 1998, pp. 160-160
Authors:
RIPAMONTI C
FULFARO F
TICOZZI C
CASUCCIO A
DECONNO F
Citation: C. Ripamonti et al., ROLE OF PAMIDRONATE DISODIUM IN THE TREATMENT OF METASTATIC BONE-DISEASE, Tumori, 84(4), 1998, pp. 442-455
Authors:
RIPAMONTI C
ZECCA E
DECONNO F
Citation: C. Ripamonti et al., PHARMACOLOGICAL TREATMENT OF CANCER PAIN - ALTERNATIVE ROUTES OF OPIOID ADMINISTRATION, Tumori, 84(3), 1998, pp. 289-300
Authors:
VANEGAS G
RIPAMONTI C
SBANOTTO A
DECONNO F
Citation: G. Vanegas et al., SIDE-EFFECTS OF MORPHINE ADMINISTRATION IN CANCER-PATIENTS, Cancer nursing, 21(4), 1998, pp. 289-297
Authors:
RIPAMONTI C
ZECCA E
BRUNELLI C
FULFARO F
VILLA S
BALZARINI A
BOMBARDIERI E
DECONNO F
Citation: C. Ripamonti et al., A RANDOMIZED, CONTROLLED CLINICAL-TRIAL TO EVALUATE THE EFFECTS OF ZINC-SULFATE ON CANCER-PATIENTS WITH TASTE ALTERATIONS CAUSED BY HEAD AND NECK IRRADIATION, Cancer, 82(10), 1998, pp. 1938-1945
Authors:
RIPAMONTI C
BRUERA E
Citation: C. Ripamonti et E. Bruera, CNS ADVERSE-EFFECTS OF OPIOIDS IN CANCER-PATIENTS - GUIDELINES FOR TREATMENT, CNS DRUGS, 8(1), 1997, pp. 21-37
Authors:
RIPAMONTI C
DECONNO F
Citation: C. Ripamonti et F. Deconno, RECTAL OPIOID MEDICATIONS - OUR EXPERIENCES, Journal of pain and symptom management, 13(5), 1997, pp. 250-251
Authors:
RIPAMONTI C
BRUERA E
Citation: C. Ripamonti et E. Bruera, DYSPNEA - PATHOPHYSIOLOGY AND ASSESSMENT, Journal of pain and symptom management, 13(4), 1997, pp. 220-232
Authors:
RIPAMONTI C
BRUERA E
Citation: C. Ripamonti et E. Bruera, UNTITLED - REPLY, Pain, 73(1), 1997, pp. 114-115
Authors:
RIPAMONTI C
ZECCA E
BRUERA E
Citation: C. Ripamonti et al., AN UPDATE ON THE CLINICAL USE OF METHADONE FOR CANCER PAIN, Pain, 70(2-3), 1997, pp. 109-115
Authors:
RIPAMONTI C
GERBINO W
Citation: C. Ripamonti et W. Gerbino, INVERSION OF WHITES EFFECT, Investigative ophthalmology & visual science, 38(4), 1997, pp. 4183-4183
Authors:
DOMINI F
RIPAMONTI C
CAUDEK C
Citation: F. Domini et al., FREQUENCY OF PRESENTATION OF LOCAL FEATURES AND OBJECT RECOGNITION, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3016-3016
Authors:
GERLI GC
CARRARO MC
DELSANTO A
RIPAMONTI C
TAGLIABUE L
MAIOLI C
CEREDA A
CARPANI G
CROSIGNANI A
Citation: Gc. Gerli et al., ANEMIA IN PRIMARY BILIARY-CIRRHOSIS - DOES BLUNTED ERYTHROPOIETIN PRODUCTION PLAY A ROLE, Blood, 90(10), 1997, pp. 2744-2744
Authors:
CARRARO MC
GONNELLA P
RIPAMONTI C
DELSANTO A
CAPPELLINI MD
COMINO A
GERLI GC
Citation: Mc. Carraro et al., HEMOGLOBIN SC DISEASE AND PROLIFERATIVE RETINOPATHY - UNUSUAL OBSERVATION IN ITALY, Blood, 90(10), 1997, pp. 2791-2791
Authors:
HANKS GW
DECONNO F
RIPAMONTI C
VENTAFRIDDA V
HANNA M
MCQUAY HJ
MERCADANTE S
MEYNADIER J
POULAIN P
CASAS JRI
SAWE J
TWYCROSS RG
VAINIO A
ZECH D
Citation: Gw. Hanks et al., FORTNIGHTLY REVIEW - MORPHINE IN CANCER PAIN - MODES OF ADMINISTRATION, BMJ. British medical journal, 312(7034), 1996, pp. 823-826
Authors:
RADAELLI F
CALORI R
RIPAMONTI C
FACCINI P
Citation: F. Radaelli et al., TREATMENT OF MYELOPROLIFERATIVE SYNDROME WITH HYDROXYUREA, Annals of hematology, 73(4), 1996, pp. 205-205
Authors:
BRUERA E
FAINSINGER RL
SCHOELLER T
RIPAMONTI C
Citation: E. Bruera et al., RAPID DISCONTINUATION OF HYPNOTICS IN TERMINAL CANCER-PATIENTS - A PROSPECTIVE-STUDY, Annals of oncology, 7(8), 1996, pp. 855-856
Authors:
DECONNO F
GROFF L
BRUNELLI C
ZECCA E
VENTAFRIDDA V
RIPAMONTI C
Citation: F. Deconno et al., CLINICAL-EXPERIENCE WITH ORAL METHADONE ADMINISTRATION IN THE TREATMENT OF PAIN IN 196 ADVANCED CANCER-PATIENTS, Journal of clinical oncology, 14(10), 1996, pp. 2836-2842